 Tourette syndrome recent advances Clinical genetic studies limits Tourette syndrome strong evidence chronic motor tics Tourette different manifestations autosomal dominant gene high penetrance genetic link obsessive-compulsive disorder cases Tourette syndrome nongenetic phenocopies association Tourette syndrome attention deficit hyperactivity disorder therapy psychostimulant drugs tics individuals high proportion patients Tourette syndrome neuropsychological deficits disabilities pathophysiology understood supported hypothesis dopamine receptor supersensitivity strong suggestions abnormalities serotonin metabolism possibility abnormalities neuropeptide systems Treatment tics relies neuroleptics dopamine receptor activity Clonidine useful patients behavior problems Obsessive-compulsive symptoms appropriate pharmacologic agents treatment attention deficit disorder patients tics behavioral strategies first-line drug psychostimulants necessary great caution rare instances necessary psychostimulant neuroleptic